2m 2m 2m 2m 2m 2m 2m
- $350.00Market Cap
- -99.67%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Clever Leaves (CLVR)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 39
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 08/18/2026
Company Profile
Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment cultivates, extracts, manufactures, commercializes, and distributes cannabinoid products comprising cannabis flowers, cannabidiol isolates, full spectrum and standardized extracts, and dry smokable flowers internationally. The Non-Cannabinoid segment formulates, manufactures, markets, sells, distributes, and commercializes nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, and oral solutions; and tetrahydrocannabinol flowers. The company serves retail distributors, pharmaceutical and cannabis companies, and pharmacies. Clever Leaves Holdings Inc. was founded in 2017 and is based in Tocancipá, Colombia.
Key Executives
- Henry R. Hague
- Andres Fajardo
- Julian Wilches
- Marta Pinto Leite
- Jackie Keshner
Current Ownership Distribution
- Mutual Funds98.2M (63.81%)
- Institutions52.0M (33.77%)
- Insiders3.7M (2.41%)
- Other0 (0.00%)